Quantify

Biogen Inc. vs Vertex Pharmaceuticals Incorpor — Stock Comparison

Biogen Inc. (BIIB) and Vertex Pharmaceuticals Incorpor (VRTX) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

BIIB
Biogen Inc.
$193.76
▲ 2.26%
vs
VRTX
Vertex Pharmaceuticals Incorpor
$434.52
▲ 0.23%
Q·Score Winner
Vertex Pharmaceuticals Incorpor
VRTX8.5/10vs 7.5/10

Vertex Pharmaceuticals Incorpor scores ahead of Biogen Inc. on Q·Score (8.5 vs 7.5 out of 10), led by Quality (9.3 vs 7) and Valuation (8.1 vs 6.4). Biogen Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for VRTX (+26.1%) than for BIIB (+13.2%).

Q·Score Breakdown

7.5
Bullish
Overall
8.5
Very Bullish
7
Quality
9.3
9.7
Health
9.2
7.8
Growth
7.4
6.4
Valuation
8.1
6.4
Sentiment
8
BIIB

Clean balance sheet with low leverage (0.4× debt-to-equity).

VRTX

High-quality business with 24% return on equity and 36% profit margins.

Analyst Consensus

Bullish
+13.2%
Target $219.27
29 analysts
Bullish
+26.1%
Target $548.10
29 analysts

Fundamentals

BIIB
VRTX
20.8×
Trailing P/E
25.8×
11.7×
Forward P/E
20.2×
13.80%
Profit Margin
35.51%
78.72%
Gross Margin
54.39%
7.70%
ROE
24.20%
1.90%
Revenue Growth
7.80%
31.10%
Earnings Growth
61.40%
0.20
Beta
0.30
$28.6B
Market Cap
$110.3B
52-Week Range
BIIB
$12186% of range$206
VRTX
$36350% of range$508

Frequently Asked Questions

BIIB vs VRTX: which stock scores better overall?

Based on Q·Score, Vertex Pharmaceuticals Incorpor (VRTX) scores 8.5/10 versus Biogen Inc. (BIIB) at 7.5/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: BIIB or VRTX?

Biogen Inc. (BIIB) scores higher on Growth (7.8/10 vs 7.4/10). Biogen Inc. reports revenue growth (1.9% YoY) while Vertex Pharmaceuticals Incorpor reports (7.8% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is BIIB or VRTX more attractively valued?

Vertex Pharmaceuticals Incorpor (VRTX) scores higher on Valuation (8.1/10 vs 6.4/10). BIIB trades at 11.7× P/E versus VRTX at 20.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about BIIB vs VRTX?

There are 29 analysts covering BIIB with a consensus price target of $219.27, and 29 analysts covering VRTX with a consensus target of $548.10. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: BIIB or VRTX?

Vertex Pharmaceuticals Incorpor (VRTX) scores higher on Quality (9.3/10 vs 7/10). Net profit margin: BIIB at 13.8%, VRTX at 35.5%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: BIIB or VRTX?

Biogen Inc. (BIIB) scores higher on Financial Health (9.7/10 vs 9.2/10). Market beta: BIIB at 0.20, VRTX at 0.30. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of BIIB and VRTX?

Biogen Inc. (BIIB) has a market capitalisation of $28.6B, while Vertex Pharmaceuticals Incorpor (VRTX) has a market cap of $110.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Related Comparisons

BIIB vs REGN

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026